Launch of VivaGel® BV in Asian countries

  • Feb 13, 2020 AEDT
  • Team Kalkine

On 13 February 2020, Starpharma Holdings Limited (ASX: SPL) announced the launch of its product VivaGel® BV under the brand name of BETADINETM BV Gel in South East Asia region along with Mundipharma’s marketing and regulatory teams.

With this launch in Asia, the Company foresees a huge commercial opportunity of having access to nearly 1.5 billion women.

Asia being the third region to grant the permission of VivaGel® BV, the Company has plans to launch the product in other Mundipharma regions, subject to regulatory approvals.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK